C-MER Eye Care Holdings Limited (3309) Stock Price & Analysis

2 Followers

3309 Stock Chart & Stats

HK$0.97HK$0.03(2.65%)

At close: Nov 11 4:00 PM GMT+8

Day’s Range: HKD 0.94 - HKD 0.99
52-Week Range: HKD 0.73 - HKD 1.85
Previous Close: HKD 0.95
Volume: N/A
Average Volume (3M): 407.36K
Market Cap: HKD 1.16B
Enterprise Value: HKD 1.15B
Total Cash (Recent Filing): HKD 563.37M
Total Debt (Recent Filing): HKD 433.61M
Price to Earnings (P/E): 11.5
Beta: 0.85
Next Earnings: Mar 30, 2027 (Est.)
EPS Estimate: N/A
Last Dividend Ex-Date: Jun 29, 2026
Dividend Yield: 2.12%

Bulls Say, Bears Say

Bulls Say

Strong Cash Generation

Consistently positive operating cash flow and strong free cash flow provide internal funding for clinical expansion, investment, and shareholder returns. The 2025 improvement in free cash flow further supports the durability of cash conversion and reduces reliance on external financing.

Moderate Balance-Sheet Leverage

Moderate leverage and a growing equity base give the company financial flexibility as it operates and expands its ophthalmic care network. A stable asset base and manageable debt burden can help the business absorb earnings variability without excessive balance-sheet pressure.

Expanded Revenue And Recovered Margins

Material revenue expansion demonstrates increasing scale across the company’s eye-care services platform. The return to profitability in 2025, alongside healthy gross and EBITDA margins, indicates that the expanded revenue base can support attractive operating economics when execution is favorable.

Bears Say

Volatile Profitability

Repeated swings between profit and loss make earnings power less predictable than the company’s cash generation alone suggests. This volatility can complicate planning, reduce confidence in sustainable returns, and leave future results more sensitive to operating execution and changes in business conditions.

Uneven Free Cash Flow Development

Strong absolute free cash flow is supportive, but uneven year-to-year growth makes the pace of internally funded expansion difficult to forecast. Variability can affect investment timing and shareholder distributions, even when the underlying business continues to generate positive cash.

Inconsistent Shareholder Returns

The inconsistent record of returns to shareholders shows that balance-sheet resources have not yet translated into dependable value creation. Negative years and only modest positive outcomes in other periods may constrain investor confidence until profitability and capital productivity become more consistent.

C-MER Eye Care Holdings Limited News

C-MER Medical Posts Higher Revenue but Softer Adjusted Profit in First Half of 2026

An update from C-MER Eye Care Holdings Limited ( ($HK:3309) ) is now available. C-MER Medical Holdings Limited reported unaudited interim results for the six months ended 30 June 2026,

2M ago3309

C-MER Completes Strategic Investment in CHIGENOVO and Secures Exclusive Rights to ZVS101e

C-MER Eye Care Holdings Limited ( ($HK:3309) ) has shared an update. C-MER Medical Holdings Limited has completed its previously announced investment transactions in CHIGENOVO Co., Ltd., a move that

3M ago3309

C-MER Medical Sets August Board Meeting to Approve Interim Results and Consider Dividend

C-MER Eye Care Holdings Limited ( ($HK:3309) ) just unveiled an announcement. C-MER Medical Holdings Limited has scheduled a board meeting for 25 August 2026 to review and approve the

3M ago3309

C-MER Seeks Exclusive Hong Kong, Macau Rights to New Eye Drug in Strategic Series B Deal

C-MER Eye Care Holdings Limited ( ($HK:3309) ) just unveiled an update. C-MER Medical Holdings is pursuing a strategic investment that includes acquiring about 10.23% of a target company and

4M ago3309

C-MER Medical Wins Shareholder Backing for Dividends and Capital Mandates at AGM

C-MER Eye Care Holdings Limited ( ($HK:3309) ) just unveiled an announcement. Shareholders of C-MER Medical Holdings Limited have approved all resolutions at the company’s annual general meeting held on

5M ago3309

C-MER Medical to Take 10.23% Stake in Target Firm via RMB112.6 Million Deal

The latest announcement is out from C-MER Eye Care Holdings Limited ( ($HK:3309) ). C-MER Medical Holdings, via its subsidiary HK (International) Eye Care, has agreed to subscribe for new

5M ago3309

C-MER Medical Sets 2026 AGM With Dividend Proposals and Share Buy-Back Mandate

C-MER Eye Care Holdings Limited ( ($HK:3309) ) just unveiled an announcement. C-MER Medical Holdings Limited has called its annual general meeting for 20 May 2026 in Central, Hong Kong,

6M ago3309

C-MER Medical Announces Special Cash Dividend for 2025

The latest announcement is out from C-MER Eye Care Holdings Limited ( ($HK:3309) ). C-MER Medical Holdings Limited has declared a special cash dividend of HKD 0.01 per share for

7M ago3309

C-MER Medical Swings Back to Profit on Higher Margins and Lower Impairments

C-MER Eye Care Holdings Limited ( ($HK:3309) ) has shared an announcement. C-MER Medical Holdings Limited reported a modest 1.8% rise in revenue to HK$1.95 billion for 2025 but delivered

7M ago3309

C-MER Medical Declares HKD 0.02 Final Dividend for FY2025

C-MER Eye Care Holdings Limited ( ($HK:3309) ) has provided an update. C-MER Medical Holdings Limited has declared a final ordinary cash dividend of HKD 0.02 per share for the

7M ago3309

3309 FAQ

What was C-MER Eye Care Holdings Limited’s price range in the past 12 months?

C-MER Eye Care Holdings Limited lowest stock price was HK$0.73 and its highest was HK$1.85 in the past 12 months.

What is C-MER Eye Care Holdings Limited’s market cap?

C-MER Eye Care Holdings Limited’s market cap is HK$1.16B.

When is C-MER Eye Care Holdings Limited’s upcoming earnings report date?

The company’s upcoming earnings report date is not yet available.

How were C-MER Eye Care Holdings Limited’s earnings last quarter?

C-MER Eye Care Holdings Limited released its earnings results on Aug 25, 2026. The company reported HK$0.055 earnings per share for the quarter.

Is C-MER Eye Care Holdings Limited overvalued?

Not enough analysts have published a price target to calculate whether the price is overvalued.

Does C-MER Eye Care Holdings Limited pay dividends?

C-MER Eye Care Holdings Limited pays an annual dividend of HK$0.03 which represents an annual dividend yield of 2.12%. See more information on C-MER Eye Care Holdings Limited dividends here

What is C-MER Eye Care Holdings Limited’s EPS estimate?

C-MER Eye Care Holdings Limited’s EPS estimate for its next earnings report is not yet available.

How many shares outstanding does C-MER Eye Care Holdings Limited have?

C-MER Eye Care Holdings Limited has 1,232,342,900 shares outstanding.

What happened to C-MER Eye Care Holdings Limited’s price movement after its last earnings report?

C-MER Eye Care Holdings Limited reported an EPS of HK$0.055 in its last earnings report. Following the earnings report the stock price went up 0.588%.

Which hedge fund is a major shareholder of C-MER Eye Care Holdings Limited?

Currently, no hedge funds are holding shares in HK:3309

What is the TipRanks Smart Score and how is it calculated?

Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology

C-MER Eye Care Holdings Limited Stock Smart Score

Neutral

Learn more about TipRanks Smart Score

Top Smart Score Stocks >

Company Description